Medical intermediate reaction kettle

Abstract

The utility model discloses a medicine intermediate reaction kettle which comprises a reaction kettle main body, a control assembly and a feed port are fixedly connected to the outer side of the reaction kettle main body respectively, a discharge port is fixedly connected to the center of the bottom of the reaction kettle main body, and supporting legs are fixedly connected to the outer side of the bottom of the discharge port. A driving box is fixedly connected to the top of the reaction kettle main body, a water injection port is fixedly connected to the center of the top of the driving box, a rotating joint is movably connected to the bottom of the water injection port, a driving motor is fixedly connected to the interior of the driving box, and a driving shaft is fixedly connected to the driving end of the driving motor in a penetrating mode and fixedly connected with the rotating joint; the outer side of the driving shaft is respectively and fixedly connected with a cross beam, a water sprayer and a stirring blade, one side of the cross beam is fixedly connected with a cleaning pipe, one side of the cleaning pipe is fixedly connected with a scraping plate, and a cavity is formed in the driving shaft.

Description

Technical Field

[0001] The utility model relates to the technical field of reaction kettles, in particular to a pharmaceutical intermediate reaction kettle. Background Art

[0002] Reactors are widely used in the fields of petroleum, chemical industry, rubber, pesticide, dye, medicine and food. They are pressure vessels used to complete processes such as vulcanization, nitration, hydrogenation, hydrocarbonization, polymerization and condensation, such as reactors, reaction pots, decomposition pots, polymerization pots, etc.; the materials are generally carbon manganese steel, stainless steel, zirconium, nickel-based alloys and other composite materials. Reactors are needed in the production of pharmaceutical intermediates.

[0003] The patent document with the prior art publication number CN216269316U provides a pharmaceutical intermediate reactor, which relates to the technical field of reactors and solves the problems that the stirring and heating in the existing reactors are not uniform enough, which will lead to incomplete internal reactions and affect the yield. A pharmaceutical intermediate reactor comprises a reactor lining layer, a sealing cover is installed in the middle of the upper end surface of the reactor lining layer, a gear protection shell is installed above the sealing cover, a servo motor protection shell is installed above the gear protection shell, a servo motor placement bin is arranged inside the servo motor protection shell, a servo motor is installed inside the servo motor placement bin, an active shaft is installed at one end of the servo motor, and four support feet are installed at the four end corners of the lower end surface of the servo motor protection shell, and the support feet are evenly distributed. The utility model has a simple structure, uniform heating, and sufficient and thorough stirring, which greatly improves the productivity of pharmaceutical intermediates.

[0004] However, the innovation of the existing pharmaceutical intermediate reactor has always made step-by-step progress in all aspects. However, when using the pharmaceutical intermediate reactor, the inside of the reactor needs to be heated. After heating, as the stirring blades stir the drugs, the stirring blades will stir the drugs to the inner wall of the reactor. After the stirring is completed, as the drugs cool, the drug residues will stick to the inside of the reactor. At this time, the reactor needs to be cleaned. However, as a closed container, the reactor becomes very troublesome when cleaning, which will increase the workload of workers and delay the progress of work. For this reason, we propose a pharmaceutical intermediate reactor. Utility Model Content

[0005] 1. Technical issues to be resolved

[0006] In view of the deficiencies in the prior art, the utility model provides a pharmaceutical intermediate reactor to solve the problem in the above background technology that drug residues stick to the inside of the reactor. As a closed container, the reactor is very troublesome to clean, which increases the workload of workers and delays work progress.

[0007] (II) Technical solution

[0008] To achieve the above objectives, the utility model is implemented through the following technical solutions: a pharmaceutical intermediate reactor, comprising a reactor body, the outer sides of the reactor body are respectively fixedly connected with a control component and a feed port, a discharge port is fixedly connected to the center of the bottom of the reactor body, a support leg is fixedly connected to the outer side of the bottom of the discharge port, a drive box is fixedly connected to the top of the reactor body, a water injection port is fixedly connected to the center of the top of the drive box, a rotary joint is movably connected to the bottom of the water injection port, a drive motor is fixedly connected to the inside of the drive box, a drive shaft is fixedly connected to the drive end of the drive motor, the drive shaft is fixedly connected to the rotary joint, a crossbeam, a sprinkler and a stirring blade are respectively fixedly connected to the outside of the drive shaft, a cleaning pipe is fixedly connected to one side of the crossbeam, a scraper is fixedly connected to one side of the cleaning pipe, and a cavity is opened inside the drive shaft.

[0009] Preferably, the control assembly includes a control panel, a display screen and control buttons. The control panel is fixedly connected to the outside of the reactor body, and the front of the control panel is fixedly connected to the display screen and the control buttons.

[0010] Preferably, a cavity is provided inside the driving shaft, and the outer surface of the driving shaft is smooth.

[0011] Preferably, the inner wall of the rotary joint is movably connected with a spring bead, and the rotary joint is movably connected to the drive shaft through the spring bead.

[0012] Preferably, a heat dissipation hole is opened on the top of the drive box, and a plurality of heat dissipation holes are provided, and the heat dissipation holes are arranged at equal intervals.

[0013] Preferably, the reactor body is made of metal material and has a hollow structure.

[0014] (III) Beneficial effects

[0015] The utility model provides a pharmaceutical intermediate reaction kettle, which has the following beneficial effects:

[0016] (1) This type of retractable exhibition seat is provided with a water injection port, a cavity, a scraper and a water sprayer. After the drug processing is completed, the drug is released from the discharge port, and water enters from the water injection port, enters the cavity through the rotary joint, and is sprayed from the water sprayer to clean the inner wall of the reactor body. At this time, the drive motor continues to work to drive the drive shaft to rotate, and the drive shaft drives the crossbeam to rotate inside the reactor body. The scraper cleans the inner wall of the drive shaft and scrapes off the residual drug. The water sprayed from the water sprayer washes off the residue and discharges the residual drug liquid through the discharge port to solve the problem of drug residues sticking to the inside of the reactor. The reactor is a closed container, which is very troublesome to clean, increasing the workload of workers and delaying work progress. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 It is a schematic diagram of the overall structure of the reactor body of the utility model;

[0018] Figure 2 It is a cross-sectional view of the main body of the reaction kettle of the utility model;

[0019] Figure 3 It is a cross-sectional view of the drive shaft of the utility model;

[0020] Figure 4 It is a partial structural schematic diagram of the rotary joint of the utility model.

[0021] In the figure: 1. Reactor body; 2. Support legs; 3. Feed inlet; 301. Discharge outlet; 4. Control panel; 5. Display screen; 6. Control buttons; 7. Drive box; 701. Heat dissipation holes; 8. Water inlet; 9. Rotary joint; 901. Spring ball; 10. Drive motor; 11. Drive shaft; 1101. Cavity; 12. Crossbeam; 1201. Cleaning pipe; 13. Scraper; 14. Sprinkler; 15. Stirring blade. DETAILED DESCRIPTION

[0022] The technical solutions in the embodiments of the utility model will be clearly and completely described below in conjunction with the drawings in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, rather than all of the embodiments. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the utility model.

[0023] See also Figure 1-4The utility model provides a technical solution: a pharmaceutical intermediate reactor, comprising a reactor body 1, the outer side of the reactor body 1 is respectively fixedly connected with a control component and a feed port 3, a discharge port 301 is fixedly connected to the center of the bottom of the reactor body 1, and a support leg 2 is fixedly connected to the outer side of the bottom of the discharge port 301, a driving box 7 is fixedly connected to the top of the reactor body 1, a water injection port 8 is fixedly connected to the center of the top of the driving box 7, and a rotary joint 9 is movably connected to the bottom of the water injection port 8, a driving motor 10 is fixedly connected to the inside of the driving box 7, a driving end of the driving motor 10 is fixedly connected with a driving shaft 11, and the driving shaft 11 is fixedly connected to the rotary joint 9, and a crossbeam 12, a sprinkler 14 and a stirring blade 15 are respectively fixedly connected to the outside of the driving shaft 11, a cleaning pipe 1201 is fixedly connected to one side of the crossbeam 12, a scraper 13 is fixedly connected to one side of the cleaning pipe 1201, and a cavity 1101 is opened inside the driving shaft 11.

[0024] In this embodiment, specifically, the control component includes a control panel 4, a display screen 5 and a control button 6. The control panel 4 is fixedly connected to the outside of the reactor body 1. The display screen 5 and the control button 6 are fixedly connected to the front of the control panel 4. The drive motor 10 is started by the control button 6 on the control panel 4.

[0025] In this embodiment, specifically, a cavity 1101 is provided inside the driving shaft 11 , the outer surface of the driving shaft 11 is smooth, and there is water inside the cavity 1101 , which can clean the inner wall of the kettle body 1 .

[0026] In this embodiment, specifically, the inner wall of the rotary joint 9 is movably connected with a spring bead 901, and the rotary joint 9 is movably connected to the driving shaft 11 through the spring bead 901. The water injection port 8 through the spring bead 901 will not rotate as the driving shaft 11 rotates.

[0027] In this embodiment, specifically, a heat dissipation hole 701 is opened on the top of the driving box 7, and a plurality of heat dissipation holes 701 are provided. The heat dissipation holes 701 are arranged at equal intervals, and the heat dissipation holes 701 can discharge the heat generated by the operation of the driving motor 10.

[0028] In this embodiment, specifically, the reactor body 1 is made of metal material, and the reactor body 1 has a hollow structure. The reactor body 1 made of metal material is not easy to chemically react with drugs.

[0029] Working principle: After the utility model is installed, first check the installation and safety protection of the utility model. When the staff uses the pharmaceutical intermediate reactor, pour the medicine from the feed port 3 into the interior of the reactor body 1, and start the drive motor 10 through the control button 6 on the control panel 4. After the drive motor 10 is started, it rotates with the drive shaft 11. The crossbeam 12 and the stirring blade 15 on the outside of the drive shaft 11 rotate inside the reactor body 1 to stir the medicine. After the drug processing is completed, the drug is discharged from the discharge port 301. Water enters from the water injection port 8, enters the cavity 1101 through the rotary joint 9, and is sprayed out from the water sprayer 14 to clean the inner wall of the reactor body 1. At this time, the drive motor 10 continues to work to drive the drive shaft 11 to rotate, and the drive shaft 11 drives the crossbeam 12 to rotate inside the reactor body 1. The scraper 13 cleans the inner wall of the reactor body 1 and scrapes off the residual medicine. The water sprayed from the water sprayer 14 washes off the residue, and the residual liquid is discharged through the discharge port 301. In this way, the use process of the utility model is completed. The utility model has a simple structure and is safe and convenient to use.

[0030] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

[0031] In the present invention, unless otherwise clearly specified and limited, the terms "installed", "connected", "connected", "fixed" and the like should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral one; it can be a mechanical connection, an electrical connection, or communication with each other; it can be a direct connection, or an indirect connection through an intermediate medium, it can be the internal connection of two elements or the interaction relationship between two elements, unless otherwise clearly defined. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.

[0032] Obviously, the embodiments described above are only some embodiments of the utility model, rather than all embodiments. The preferred embodiments of the utility model are given in the accompanying drawings, but they do not limit the patent scope of the utility model. The utility model can be implemented in many different forms. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the utility model more thorough and comprehensive. Although the utility model is described in detail with reference to the aforementioned embodiments, for those skilled in the art, it is still possible to modify the technical solutions recorded in the aforementioned specific implementation methods, or to replace some of the technical features therein with equivalents. Any equivalent structure made using the contents of the utility model specification and the accompanying drawings, directly or indirectly used in other related technical fields, is also within the scope of patent protection of the utility model.

Claims

1. A pharmaceutical intermediate reactor, comprising a reactor body (1), characterized in that: The outside of the reactor body (1) is respectively fixedly connected with a control component and a feed port (3); the center of the bottom of the reactor body (1) is fixedly connected with a discharge port (301); the outside of the bottom of the discharge port (301) is fixedly connected with a support leg (2); the top of the reactor body (1) is fixedly connected with a drive box (7); the center of the top of the drive box (7) is fixedly connected with a water injection port (8); the bottom of the water injection port (8) is movably connected with a rotary joint (9); the inside of the drive box (7) is fixedly connected with a rotating joint (9); A driving motor (10) is connected, a driving end of the driving motor (10) is penetrated and fixedly connected with a driving shaft (11), the driving shaft (11) is fixedly connected to a rotary joint (9), a crossbeam (12), a water sprayer (14) and a stirring blade (15) are respectively fixedly connected to the outside of the driving shaft (11), a cleaning pipe (1201) is fixedly connected to one side of the crossbeam (12), a scraper (13) is fixedly connected to one side of the cleaning pipe (1201), and a cavity (1101) is opened inside the driving shaft (11).

2. A pharmaceutical intermediate reaction kettle as claimed in claim 1, characterized in that: The control assembly comprises a control panel (4), a display screen (5) and control buttons (6); the control panel (4) is fixedly connected to the outside of the reactor body (1); and the display screen (5) and the control buttons (6) are fixedly connected to the front of the control panel (4).

3. A pharmaceutical intermediate reaction kettle as claimed in claim 1, characterized in that: A cavity (1101) is provided inside the driving shaft (11), and the outer surface of the driving shaft (11) is smooth.

4. A pharmaceutical intermediate reaction kettle as claimed in claim 1, characterized in that: The inner wall of the rotary joint (9) is movably connected to a spring bead (901), and the rotary joint (9) is movably connected to the drive shaft (11) via the spring bead (901).

5. A pharmaceutical intermediate reaction kettle as claimed in claim 1, characterized in that: The top of the drive box (7) is provided with a heat dissipation hole (701), a plurality of the heat dissipation holes (701) are provided, and the heat dissipation holes (701) are arranged at equal distances.

6. A pharmaceutical intermediate reaction kettle as claimed in claim 1, characterized in that: The reactor body (1) is made of metal material and has a hollow structure.

Images